Davis Polk advised the representatives of the several purchasers in offering.Ionis Pharmaceuticals, Inc. executed its offering of an aggregate principal amount of $632.5 million of its 0%…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now